kw.\*:("Pneumococcal vaccine")
Results 1 to 25 of 235
Selection :
Impact of pneumococcal vaccination on morbidity and mortality of geriatric patients: A case-controlled studyWAGNER, Christian; POPP, Wolfgang; POSCH, Martin et al.Gerontology (Basel). 2003, Vol 49, Num 4, pp 246-250, issn 0304-324X, 5 p.Article
A qualitative study on knowledge, perceptions, and attitudes of mothers and health care providers toward pneumococcal conjugate vaccine in Bandung, West Java, IndonesiaTRI HARJANINGRUM, Agnes; KARTASASMITA, Cissy; ORNE-GLIEMANN, Joanna et al.Vaccine. 2013, Vol 31, Num 11, pp 1516-1522, issn 0264-410X, 7 p.Article
Optimizing expression of Streptococcus pneumoniae surface protein a, PspA : Serocross-reactivity within families of antisera induced against clades 1 and 3SILVA, Marcelo; CABRERA-CRESPO, Joaquin; SBROGIO-ALMEIDA, Maria E et al.Molecular biotechnology. 2007, Vol 37, Num 2, pp 146-154, issn 1073-6085, 9 p.Article
Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink populationJACKSON, Lisa A; NELSON, Jennifer C; WHITNEY, Cynthia G et al.Vaccine. 2006, Vol 24, Num 2, pp 151-156, issn 0264-410X, 6 p.Article
Current trend of pneumococcal serotypes distribution and antibiotic susceptibility pattern in Malaysian hospitalsMD YASIN, Rohani; MOHD ZIN, Norni; NAZRI AZIZ, Muhhamad et al.Vaccine. 2011, Vol 29, Num 34, pp 5688-5693, issn 0264-410X, 6 p.Article
A qualitative study to assess the perceived benefits and barriers to the pneumococcal vaccine in hospitalised older peopleRIDDA, I; MACLNTYRE, C. R; LINDLEY, R. I et al.Vaccine. 2009, Vol 27, Num 28, pp 3775-3779, issn 0264-410X, 5 p.Article
Does pneumococcal vaccine reduce influenza morbidity in humans?BLAY, A; BESSLER, H; LAHAD, A et al.Vaccine. 2007, Vol 25, Num 6, pp 1071-1075, issn 0264-410X, 5 p.Article
The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and overKELLY, Heath; ATTIA, John; ANDREWS, Ross et al.Vaccine. 2004, Vol 22, Num 17-18, pp 2192-2198, issn 0264-410X, 7 p.Article
Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineJACKSON, Lisa A; NEUZIL, Kathleen M; CARSTE, Barb et al.Vaccine. 2005, Vol 23, Num 28, pp 3697-3703, issn 0264-410X, 7 p.Article
Post-marketing effectiveness of Prevnar [pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein)] and implications for adult immunizationABRAHAM-VAN PARIJS, Betsy; MALINOSKI, Frank J.Mechanisms of ageing and development. 2004, Vol 125, Num 2, pp 147-148, issn 0047-6374, 2 p.Conference Paper
Animal models for protein pneumococcal vaccine evaluation : A summarySTEINHOFF, M. C.Vaccine. 2007, Vol 25, Num 13, pp 2465-2470, issn 0264-410X, 6 p.Conference Paper
Social support is positively associated with the immunoglobulin M response to vaccination with pneumococcal polysaccharidesGALLAGHER, Stephen; PHILLIPS, Anna C; FERRARO, Alastair J et al.Biological psychology. 2008, Vol 78, Num 2, pp 211-215, issn 0301-0511, 5 p.Article
Report from a WHO Working group: Standard method for detecting upper respiratory carriage of Streptococcus pneumoniaeO'BRIEN, Katherine L; NOHYNEK, Hanna.The Pediatric infectious disease journal. 2003, Vol 22, Num 2, pp 133-140, issn 0891-3668, 8 p.Article
Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine modelWHALEY, Melissa J; SAMPSON, Jacquelyn S; JOHNSON, Scott E et al.Vaccine. 2010, Vol 28, Num 18, pp 3071-3075, issn 0264-410X, 5 p.Article
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trialRUSSELL, F. M; CARAPETIS, J. R; CHEUNG, Y. B et al.Vaccine. 2010, Vol 28, Num 19, pp 3341-3349, issn 0264-410X, 9 p.Article
Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineJACKSON, Lisa A; NEUZIL, Kathleen M; BAGGS, James et al.Vaccine. 2007, Vol 25, Num 20, pp 4029-4037, issn 0264-410X, 9 p.Article
Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccinationDUNNE, Eileen M; SMITH-VAUGHAN, Heidi C; ROBINS-BROWNE, Roy M et al.Vaccine. 2013, Vol 31, Num 19, pp 2333-2342, issn 0264-410X, 10 p.Article
Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; A Pneumocarr meeting report March 27―28, 2012, Geneva : Nasopharyngeal Carriage in the Pneumococcal Vaccine Licensure ProcessGOLDBLATT, David; RAMAKRISHNAN, Meena; O'BRIEN, Katherine et al.Vaccine. 2013, Vol 32, Num 1, pp 146-152, issn 0264-410X, 7 p.Article
A computerized pneumococcal vaccination reminder system in the adult emergency departmentDEXHEIMER, Judith W; TALBOT, Thomas R; FEI YE et al.Vaccine. 2011, Vol 29, Num 40, pp 7035-7041, issn 0264-410X, 7 p.Article
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of ageRUSSELL, F. M; CARAPETIS, J. R; NAHM, M. H et al.Vaccine. 2011, Vol 29, Num 3, pp 535-544, issn 0264-410X, 10 p.Article
Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccineGADZINOWSKI, Janusz; ALBRECHT, Piotr; EMINI, Emilio A et al.Vaccine. 2011, Vol 29, Num 16, pp 2947-2955, issn 0264-410X, 9 p.Article
Validity of self-reported pneumococcal vaccination status in the elderly in SpainBAYAS, José-María; IZQUIERDO, Conchita; SUGRANES, Silvia et al.Vaccine. 2009, Vol 27, Num 34, pp 4560-4564, issn 0264-410X, 5 p.Article
Challenges in immunisation against bacterial infection in childrenTRÜCK, Johannes; POLLARD, Andrew J.Early human development. 2010, Vol 86, Num 11, pp 695-701, issn 0378-3782, 7 p.Conference Paper
Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk populationLEACH, Amanda J; MORRIS, Peter S; MACKENZIE, Grant et al.Vaccine. 2008, Vol 26, Num 31, pp 3885-3891, issn 0264-410X, 7 p.Article
Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal diseaseTAMURA, Kazuyo; MATSUBARA, Kousaku; ISHIWADA, Naruhiko et al.Vaccine. 2014, Vol 32, Num 13, pp 1444-1450, issn 0264-410X, 7 p.Article